← 返回公司对比

Regard

辅助临床诊断与文档的AI平台

成立年份2017
国家United States
一级垂类Healthcare
二级垂类Clinical Decision Support

AI Native:confirmed。AI直接参与临床决策支持 · 官网

1. 商业数据

收入历史

口径金额期间属性日期状态置信度
Revenue$283mcalendar_yearEst.2025-12-31reported0.6

融资与估值历史

估值类型轮次属性日期状态置信度
$350mreported_valuationSeries BEst.2024-07-11reported0.75

2. 模型与技术路线

路线修饰供应商模型关系用途日期状态置信度
未披露未披露OpenAI未披露Unknownunknown2024-10-11reported0.75

3. 算力与云

未披露

4. 来源与证据

收入:revenue reported · 置信度 0.6
ICEYE revenue, funding & news · 2026-06-29 · 原始来源
Sacra estimates [ICEYE](https://sacra.com/c/iceye/) generated $283M in 2025, up 116% YoY from $131M in 2024. [ICEYE](https://sacra.com/c/iceye/) more than doubled revenue as European defense demand translated into government satellite-intelligence contracts and the company scaled production of its synthetic-aperture radar satellites.
模型:OpenAI reported · 置信度 0.75
Regard Launches New Functionality Powered by OpenAI’s GPT-4 to Operationalize Large Language Models in Clinical Workflows · 2024-10-11 · 原始来源
Los Angeles, CA – [Regard](https://regard.com/), a software company developing an artificial intelligence (AI) co-pilot for clinicians to help diagnose medical conditions, announced today that it has expanded its relationship with [OpenAI](https://openai.com/), an AI research and development company. Through this relationship, Regard will release new core product functionalities and a new chatbot, Max, that is built on OpenAI’s large language model (LLM), GPT-4.
估值估算:reported_valuation reported · 置信度 0.75
AI-powered Regard nabs $61M to find missed illness, boost hospital revenue | TechCrunch · 2024-07-11 · 原始来源
Regard announced on Thursday that it raised a $61 million Series B round led by Oak HC/FT, with participation from Cedars-Sinai Health Ventures and existing investors TenOneTen, Calibrate Ventures and Techstars. The company is now valued at $350 million, according to a person familiar with the matter.